Global Urothelial Cancer Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 115 pages | ID: GED6F2CB55EGEN
GlobalInfoResearch

Abstracts

Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounted for approximately 90% of all urinary cancer cases.

SCOPE OF THE REPORT:

This report studies the Urothelial Cancer Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Urothelial Cancer Drugs market by product type and applications/end industries.
Market growth is largely attributed to factors such as availability of novel drugs, presence of a strong pipeline, rise in incidence of urothelial cancer due to growing geriatric population, unorganized lifestyle, and rising public awareness.
The global Urothelial Cancer Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Urothelial Cancer Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Roche
• Merck
• Bristol-Myers Squibb
• AstraZeneca
• Pfizer

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Chemotherapy
• Immunotherapy

Market Segment by Applications, can be divided into

• Hospitals
• Pharmacy

Contents

1 UROTHELIAL CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Urothelial Cancer Drugs
1.2 Classification of Urothelial Cancer Drugs by Types
  1.2.1 Global Urothelial Cancer Drugs Revenue Comparison by Types (2017-2023)
  1.2.2 Global Urothelial Cancer Drugs Revenue Market Share by Types in 2017
  1.2.3 Chemotherapy
  1.2.4 Immunotherapy
1.3 Global Urothelial Cancer Drugs Market by Application
  1.3.1 Global Urothelial Cancer Drugs Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Pharmacy
1.4 Global Urothelial Cancer Drugs Market by Regions
  1.4.1 Global Urothelial Cancer Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Urothelial Cancer Drugs Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Urothelial Cancer Drugs Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Urothelial Cancer Drugs Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Urothelial Cancer Drugs Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Urothelial Cancer Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Urothelial Cancer Drugs (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Roche
  2.1.1 Business Overview
  2.1.2 Urothelial Cancer Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Roche Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
  2.2.1 Business Overview
  2.2.2 Urothelial Cancer Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Merck Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol-Myers Squibb
  2.3.1 Business Overview
  2.3.2 Urothelial Cancer Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Bristol-Myers Squibb Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 AstraZeneca
  2.4.1 Business Overview
  2.4.2 Urothelial Cancer Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 AstraZeneca Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
  2.5.1 Business Overview
  2.5.2 Urothelial Cancer Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Pfizer Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL UROTHELIAL CANCER DRUGS MARKET COMPETITION, BY PLAYERS

3.1 Global Urothelial Cancer Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Urothelial Cancer Drugs Players Market Share
  3.2.2 Top 10 Urothelial Cancer Drugs Players Market Share
3.3 Market Competition Trend

4 GLOBAL UROTHELIAL CANCER DRUGS MARKET SIZE BY REGIONS

4.1 Global Urothelial Cancer Drugs Revenue and Market Share by Regions
4.2 North America Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA UROTHELIAL CANCER DRUGS REVENUE BY COUNTRIES

5.1 North America Urothelial Cancer Drugs Revenue by Countries (2013-2018)
5.2 USA Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)

6 EUROPE UROTHELIAL CANCER DRUGS REVENUE BY COUNTRIES

6.1 Europe Urothelial Cancer Drugs Revenue by Countries (2013-2018)
6.2 Germany Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
6.4 France Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC UROTHELIAL CANCER DRUGS REVENUE BY COUNTRIES

7.1 Asia-Pacific Urothelial Cancer Drugs Revenue by Countries (2013-2018)
7.2 China Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
7.5 India Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA UROTHELIAL CANCER DRUGS REVENUE BY COUNTRIES

8.1 South America Urothelial Cancer Drugs Revenue by Countries (2013-2018)
8.2 Brazil Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE UROTHELIAL CANCER DRUGS BY COUNTRIES

9.1 Middle East and Africa Urothelial Cancer Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)

10 GLOBAL UROTHELIAL CANCER DRUGS MARKET SEGMENT BY TYPE

10.1 Global Urothelial Cancer Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Urothelial Cancer Drugs Market Forecast by Type (2018-2023)
10.3 Chemotherapy Revenue Growth Rate (2013-2023)
10.4 Immunotherapy Revenue Growth Rate (2013-2023)

11 GLOBAL UROTHELIAL CANCER DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Urothelial Cancer Drugs Revenue Market Share by Application (2013-2018)
11.2 Urothelial Cancer Drugs Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Pharmacy Revenue Growth (2013-2018)

12 GLOBAL UROTHELIAL CANCER DRUGS MARKET SIZE FORECAST (2018-2023)

12.1 Global Urothelial Cancer Drugs Market Size Forecast (2018-2023)
12.2 Global Urothelial Cancer Drugs Market Forecast by Regions (2018-2023)
12.3 North America Urothelial Cancer Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Urothelial Cancer Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Urothelial Cancer Drugs Revenue Market Forecast (2018-2023)
12.6 South America Urothelial Cancer Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Urothelial Cancer Drugs Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Urothelial Cancer Drugs Picture
Table Product Specifications of Urothelial Cancer Drugs
Table Global Urothelial Cancer Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Urothelial Cancer Drugs Revenue Market Share by Types in 2017
Figure Chemotherapy Picture
Figure Immunotherapy Picture
Table Global Urothelial Cancer Drugs Revenue (Million USD) by Application (2013-2023)
Figure Urothelial Cancer Drugs Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Pharmacy Picture
Table Global Market Urothelial Cancer Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Urothelial Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Urothelial Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Urothelial Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Urothelial Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Urothelial Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Urothelial Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Urothelial Cancer Drugs Type and Applications
Table Roche Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Urothelial Cancer Drugs Type and Applications
Table Merck Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Urothelial Cancer Drugs Type and Applications
Table Bristol-Myers Squibb Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Urothelial Cancer Drugs Type and Applications
Table AstraZeneca Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Urothelial Cancer Drugs Type and Applications
Table Pfizer Urothelial Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Urothelial Cancer Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Urothelial Cancer Drugs Revenue Share by Players (2013-2018)
Figure Global Urothelial Cancer Drugs Revenue Share by Players in 2016
Figure Global Urothelial Cancer Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Urothelial Cancer Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Urothelial Cancer Drugs Revenue Market Share in 2017
Figure Global Urothelial Cancer Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Urothelial Cancer Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Urothelial Cancer Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Urothelial Cancer Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Urothelial Cancer Drugs Revenue Market Share by Regions in 2017
Figure North America Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure South America Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Table North America Urothelial Cancer Drugs Revenue by Countries (2013-2018)
Table North America Urothelial Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Urothelial Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Urothelial Cancer Drugs Revenue Market Share by Countries in 2017
Figure USA Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Europe Urothelial Cancer Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Urothelial Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Urothelial Cancer Drugs Revenue Market Share by Countries in 2017
Figure Germany Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure UK Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure France Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Urothelial Cancer Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Urothelial Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Urothelial Cancer Drugs Revenue Market Share by Countries in 2017
Figure China Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure India Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Table South America Urothelial Cancer Drugs Revenue by Countries (2013-2018)
Table South America Urothelial Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Urothelial Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Urothelial Cancer Drugs Revenue Market Share by Countries in 2017
Figure Brazil Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Urothelial Cancer Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Urothelial Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Urothelial Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Urothelial Cancer Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Urothelial Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Global Urothelial Cancer Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Urothelial Cancer Drugs Revenue Share by Type (2013-2018)
Figure Global Urothelial Cancer Drugs Revenue Share by Type (2013-2018)
Figure Global Urothelial Cancer Drugs Revenue Share by Type in 2017
Table Global Urothelial Cancer Drugs Revenue Forecast by Type (2018-2023)
Figure Global Urothelial Cancer Drugs Market Share Forecast by Type (2018-2023)
Figure Global Chemotherapy Revenue Growth Rate (2013-2018)
Figure Global Immunotherapy Revenue Growth Rate (2013-2018)
Table Global Urothelial Cancer Drugs Revenue by Application (2013-2018)
Table Global Urothelial Cancer Drugs Revenue Share by Application (2013-2018)
Figure Global Urothelial Cancer Drugs Revenue Share by Application (2013-2018)
Figure Global Urothelial Cancer Drugs Revenue Share by Application in 2017
Table Global Urothelial Cancer Drugs Revenue Forecast by Application (2018-2023)
Figure Global Urothelial Cancer Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Urothelial Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Urothelial Cancer Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Urothelial Cancer Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Urothelial Cancer Drugs Revenue Market Forecast (2018-2023)
Figure Europe Urothelial Cancer Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Urothelial Cancer Drugs Revenue Market Forecast (2018-2023)
Figure South America Urothelial Cancer Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Urothelial Cancer Drugs Revenue Market Forecast (2018-2023)